Clinical Trial Update: Fibrinolysis Resistance in Infection and Trauma

View source ↗

Summary

A clinical trial investigating fibrinolysis resistance in sepsis, septic shock, and trauma is currently recruiting. Sponsor is Anders Aneman.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock
• Trauma

Snippet

Sponsor: Anders Aneman | Conditions: Sepsis and Septic Shock, Trauma | Status: RECRUITING